FDA Considers Reclassifying Hemostatic Devices
The U.S. Food and Drug Administration is considering reclassifying absorbable hemostatic devices, used to stanch bleeding during surgery, as medium rather than high risk, so that they can be approved without...To view the full article, register now.
Already a subscriber? Click here to view full article